Quantcast

Latest Percodan Stories

2010-06-08 13:00:00

CHADDS FORD, Pa., June 8 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq: ENDP) today announced that it will present at the Jefferies 2010 Global Life Sciences Conference on Thursday, June 10, 2010, at 2:00 p.m. EDT. Alan Levin, executive vice president and chief financial officer of Endo, will review the company's products and development programs. The presentation will be webcast live and can be accessed from Endo's website at www.endo.com under the investors section. About...

2010-05-05 15:37:00

AUSTIN, Texas, May 5 /PRNewswire-FirstCall/ -- HealthTronics, Inc. (Nasdaq: HTRN), a leading provider of urological products and services, today announced that it has signed a definitive merger agreement with Endo Pharmaceuticals (Nasdaq: ENDP) pursuant to which Endo will acquire HealthTronics. Under the terms of the merger agreement, Endo will commence an all cash tender offer to acquire all of the outstanding shares of HealthTronics common stock for approximately $223 million or $4.85...

2010-05-05 15:37:00

CHADDS FORD, Pa., May 5 /PRNewswire-FirstCall/ -- HealthTronics is a Leading Provider of Urologic Products and Services All Cash Transaction with Purchase Price of $223 Million Plus Assumed Net Debt Acquisition Accretive to 2010 Adjusted Earnings Per Share Diversifies Endo Revenue Stream and Product Offering in Urology Continuing to diversify, move into new growth areas beyond pharmaceuticals, and strengthen its commitment to improved patient outcomes in urology, Endo Pharmaceuticals...

2010-05-04 07:00:00

CHADDS FORD, Pa., May 4 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq: ENDP) today announced that it will present at the Bank of America Merrill Lynch Health Care Conference on Wednesday, May 12, 2010, at 11:20 a.m. EDT. David Holveck, president and chief executive officer of Endo, will review the company's products and development programs. The presentation will be webcast live and can be accessed from Endo's website at www.endo.com under the investors section. About Endo...

2010-04-16 14:34:00

CHADDS FORD, Pa., April 16 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq: ENDP) will announce its first quarter 2010 financial results on April 30, 2010 and will host a conference call and webcast at 10:00 a.m. ET that day to discuss these results. David P. Holveck, president and chief executive officer, Alan Levin, chief financial officer and Blaine Davis, vice president, corporate affairs will host the call. In addition, Ivan Gergel, M.D., executive vice president of research...

2010-04-13 07:33:00

CHADDS FORD, Pa., April 13 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq: ENDP) and Penwest Pharmaceuticals (Nasdaq: PPCO) announced today that the companies have settled litigation with Barr Laboratories, Inc. regarding the production and sale of generic formulations of Opana® ER (oxymorphone hydrochloride) Extended Release Tablets CII. Under the terms of the settlement, Endo and Penwest have agreed to grant Barr a license to sell a generic of...

2010-03-17 08:00:00

CHADDS FORD, Pa., March 17 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq: ENDP) today announced that it will present at the Barclays Capital 2010 Global Healthcare Conference on Tuesday, Mar. 23, 2010, at 10:15 a.m. EDT. David Holveck, president and chief executive officer of Endo, will review the company's products and development programs. The presentation will be webcast live and can be accessed from Endo's website at www.endo.com under the investors section. About Endo...

2010-03-05 15:30:00

CHADDS FORD, Pa., March 5 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq: ENDP) today announced that it will present at the Cowen and Company 30th Annual Health Care Conference on Tuesday, March 9, 2010, at 10:20 a.m. EST. David Holveck, president and chief executive officer of Endo, will review the company's products and development programs. The presentation will be webcast live and can be accessed from Endo's website at www.endo.com under the investors section. About Endo...

2010-02-12 08:00:00

CHADDS FORD, Pa., Feb. 12 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq: ENDP) will announce its fourth quarter and full year 2009 financial results on February 22, 2010 and will host a conference call and webcast at 10:30 a.m. ET that day to discuss these results. David P. Holveck, president and chief executive officer, Alan Levin, chief financial officer and Blaine Davis, vice president, corporate affairs will host the call. Investors and other interested parties may call...

2010-01-26 09:00:00

Approval is part of Agency's unapproved drugs initiative SILVER SPRING, Md., Jan. 26 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved Morphine Sulfate Oral Solution for the relief of moderate to severe, acute and chronic pain in opioid-tolerant patients. This medicine will be available in 100 milligrams per 5 mL or 20 milligrams per 1 mL. (Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO) This is the only FDA-approved morphine sulfate oral...


Word of the Day
grass-comber
  • A landsman who is making his first voyage at sea; a novice who enters naval service from rural life.
According to the OED, a grass-comber is also 'a sailor's term for one who has been a farm-labourer.'